These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33845129)

  • 1. Intracellular pathways involved in cell survival are deregulated in mouse and human spinal muscular atrophy motoneurons.
    Sansa A; de la Fuente S; Comella JX; Garcera A; Soler RM
    Neurobiol Dis; 2021 Jul; 155():105366. PubMed ID: 33845129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calpain Inhibition Increases SMN Protein in Spinal Cord Motoneurons and Ameliorates the Spinal Muscular Atrophy Phenotype in Mice.
    de la Fuente S; Sansa A; Periyakaruppiah A; Garcera A; Soler RM
    Mol Neurobiol; 2019 Jun; 56(6):4414-4427. PubMed ID: 30327977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calpain system is altered in survival motor neuron-reduced cells from in vitro and in vivo spinal muscular atrophy models.
    de la Fuente S; Sansa A; Hidalgo I; Vivancos N; Romero-Guevara R; Garcera A; Soler RM
    Cell Death Dis; 2020 Jun; 11(6):487. PubMed ID: 32587237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinal Muscular Atrophy autophagy profile is tissue-dependent: differential regulation between muscle and motoneurons.
    Sansa A; Hidalgo I; Miralles MP; de la Fuente S; Perez-Garcia MJ; Munell F; Soler RM; Garcera A
    Acta Neuropathol Commun; 2021 Jul; 9(1):122. PubMed ID: 34217376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loganin possesses neuroprotective properties, restores SMN protein and activates protein synthesis positive regulator Akt/mTOR in experimental models of spinal muscular atrophy.
    Tseng YT; Chen CS; Jong YJ; Chang FR; Lo YC
    Pharmacol Res; 2016 Sep; 111():58-75. PubMed ID: 27241020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERK MAPK signaling pathway inhibition as a potential target to prevent autophagy alterations in Spinal Muscular Atrophy motoneurons.
    Sansa A; Miralles MP; Beltran M; Celma-Nos F; Calderó J; Garcera A; Soler RM
    Cell Death Discov; 2023 Apr; 9(1):113. PubMed ID: 37019880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival motor neuron protein and neurite degeneration are regulated by Gemin3 in spinal muscular atrophy motoneurons.
    Miralles MP; Sansa A; Beltran M; Soler RM; Garcera A
    Front Cell Neurosci; 2022; 16():1054270. PubMed ID: 36619669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shift from extracellular signal-regulated kinase to AKT/cAMP response element-binding protein pathway increases survival-motor-neuron expression in spinal-muscular-atrophy-like mice and patient cells.
    Branchu J; Biondi O; Chali F; Collin T; Leroy F; Mamchaoui K; Makoukji J; Pariset C; Lopes P; Massaad C; Chanoine C; Charbonnier F
    J Neurosci; 2013 Mar; 33(10):4280-94. PubMed ID: 23467345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of Survival Motor Neuron Protein by the Nuclear Factor-Kappa B Pathway in Mouse Spinal Cord Motoneurons.
    Arumugam S; Mincheva-Tasheva S; Periyakaruppiah A; de la Fuente S; Soler RM; Garcera A
    Mol Neurobiol; 2018 Jun; 55(6):5019-5030. PubMed ID: 28808928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic treatment with lithium does not improve neuromuscular phenotype in a mouse model of severe spinal muscular atrophy.
    Dachs E; Piedrafita L; Hereu M; Esquerda JE; Calderó J
    Neuroscience; 2013 Oct; 250():417-33. PubMed ID: 23876328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival motor neuron protein reduction deregulates autophagy in spinal cord motoneurons in vitro.
    Garcera A; Bahi N; Periyakaruppiah A; Arumugam S; Soler RM
    Cell Death Dis; 2013 Jun; 4(6):e686. PubMed ID: 23788043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of exercise-induced survival motor neuron expression in the skeletal muscle of spinal muscular atrophy-like mice.
    Ng SY; Mikhail A; Ljubicic V
    J Physiol; 2019 Sep; 597(18):4757-4778. PubMed ID: 31361024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal astrocyte dysfunction drives motor neuron loss in late-onset spinal muscular atrophy.
    Schmitt LI; David C; Steffen R; Hezel S; Roos A; Schara-Schmidt U; Kleinschnitz C; Leo M; Hagenacker T
    Acta Neuropathol; 2023 May; 145(5):611-635. PubMed ID: 36930296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IPLEX administration improves motor neuron survival and ameliorates motor functions in a severe mouse model of spinal muscular atrophy.
    Murdocca M; Malgieri A; Luchetti A; Saieva L; Dobrowolny G; de Leonibus E; Filareto A; Quitadamo MC; Novelli G; Musarò A; Sangiuolo F
    Mol Med; 2012 Sep; 18(1):1076-85. PubMed ID: 22669476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperexcitability precedes motoneuron loss in the
    Quinlan KA; Reedich EJ; Arnold WD; Puritz AC; Cavarsan CF; Heckman CJ; DiDonato CJ
    J Neurophysiol; 2019 Oct; 122(4):1297-1311. PubMed ID: 31365319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog.
    Ohuchi K; Funato M; Kato Z; Seki J; Kawase C; Tamai Y; Ono Y; Nagahara Y; Noda Y; Kameyama T; Ando S; Tsuruma K; Shimazawa M; Hara H; Kaneko H
    Stem Cells Transl Med; 2016 Feb; 5(2):152-63. PubMed ID: 26683872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impairment of the neurotrophic signaling hub B-Raf contributes to motoneuron degeneration in spinal muscular atrophy.
    Hensel N; Cieri F; Santonicola P; Tapken I; Schüning T; Taiana M; Pagliari E; Joseph A; Fischer S; Heidrich N; Brinkmann H; Kubinski S; Bergmann AK; Richter MF; Jung K; Corti S; Di Schiavi E; Claus P
    Proc Natl Acad Sci U S A; 2021 May; 118(18):. PubMed ID: 33931501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compensatory axon sprouting for very slow axonal die-back in a transgenic model of spinal muscular atrophy type III.
    Udina E; Putman CT; Harris LR; Tyreman N; Cook VE; Gordon T
    J Physiol; 2017 Mar; 595(5):1815-1829. PubMed ID: 27891608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A large animal model of spinal muscular atrophy and correction of phenotype.
    Duque SI; Arnold WD; Odermatt P; Li X; Porensky PN; Schmelzer L; Meyer K; Kolb SJ; Schümperli D; Kaspar BK; Burghes AH
    Ann Neurol; 2015 Mar; 77(3):399-414. PubMed ID: 25516063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Protective Effects of Levetiracetam on a Human iPSCs-Derived Spinal Muscular Atrophy Model.
    Ando S; Funato M; Ohuchi K; Inagaki S; Sato A; Seki J; Kawase C; Saito T; Nishio H; Nakamura S; Shimazawa M; Kaneko H; Hara H
    Neurochem Res; 2019 Jul; 44(7):1773-1779. PubMed ID: 31102025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.